Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma

Immunotherapy for Melanoma: The Significance of Immune Checkpoint Inhibitors for the Treatment of Advanced Melanoma

Therapeutic options for treating advanced melanoma have progressed rapidly in recent decades. Until 6 years ago, the regimen for treating advanced melanoma consisted mainly of cytotoxic agents such as dacarbazine and type I interferons. Since 2014, anti-programmed cell death 1 (PD1) antibodies have...

Full description

Bibliographic Details
Main Authors: Taku Fujimura, Yusuke Muto, Yoshihide Asano
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:International Journal of Molecular Sciences
Subjects:
immune checkpoint inhibitors
advanced melanoma
anti-PD1 Abs
anti-CTLA4 Abs
efficacy
irAEs
Online Access:https://www.mdpi.com/1422-0067/23/24/15720

Internet

https://www.mdpi.com/1422-0067/23/24/15720

Similar Items